Medicines on the single market line: Europe faces a one-bloc or country-by-country choice
The European Parliament has placed the question of joint EU medicines procurement at the centre of its May plenary, as pressure from Washington and Beijing on pharmaceutical supply chains reaches what liberals describe as a decisive moment for the Union’s negotiating leverage.
